Abstract:Implementation of effective cancer treatment strategies requires consideration of how the spatiotemporal heterogeneities within the tumor microenvironment (TME) influence tumor progression and treatment response. Here, we developed a multi-scale three-dimensional mathematical model of the TME to simulate tumor growth and angiogenesis and then employed the model to evaluate an array of single and combination therapy approaches. Treatments included maximum tolerated dose or metronomic (i.e., frequent low doses) scheduling of anti-cancer drugs combined with anti-angiogenic therapy. The results show that metronomic therapy normalizes the tumor vasculature to improve drug delivery, modulates cancer metabolism, decreases interstitial fluid pressure and decreases cancer cell invasion. Further, we find that combining an anti-cancer drug with anti-angiogenic treatment enhances tumor killing and reduces drug accumulation in normal tissues. We also show that combined anti-angiogenic and anti-cancer drugs can decrease cancer invasiveness and normalize the cancer metabolic microenvironment leading to reduced hypoxia and hypoglycemia. Our model simulations suggest that vessel normalization combined with metronomic cytotoxic therapy has beneficial effects by enhancing tumor killing and limiting normal tissue toxicity. Effective treatment of solid tumors with injected drugs requires that sufficient exposure of cancer cells to the cytotoxic drugs. However, non-uniform and poorly functioning blood vessels make this difficult. The amount of drug that reaches a given cancer cells depends on many factors, including the drug chemistry, its lifetime in the blood circulation, its ability to cross the blood vessel wall and enter the tissue, and the schedule of the injections. We present a mathematical model of tumor growth, angiogenesis, metabolism and drug transport that examines how these processes affect the response to treatment. We find that low dose, high frequency (metronomic) therapy normalizes the tumor vasculature to improve drug delivery and that combining an anti-cancer drug with a drug that specifically enhances vascular function increases tumor killing and reduces drug accumulation in normal tissues. Our model simulations suggest that vessel normalization combined with metronomic cytotoxic therapy has beneficial effects by enhancing tumor killing and limiting normal tissue toxicity.

A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth

Chemo‐mechanistic multi‐scale model of a three‐dimensional tumor microenvironment to quantify the chemotherapy response of cancer

Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment

A New Mathematical Model for Controlling Tumor Growth Based on Microenvironment Acidity and Oxygen Concentration

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

A multiscale cell‐based model of tumor growth for chemotherapy assessment and tumor‐targeted therapy through a 3D computational approach

Development of a coupled modeling for tumor growth, angiogenesis, oxygen delivery, and phenotypic heterogeneity

Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation

Mathematical Modeling of the Function of Warburg Effect in Tumor Microenvironment

Multiscale modeling of tumor adaption and invasion following anti-angiogenic therapy

Multi-scale Mathematical Modelling of Tumour Growth and Microenvironments in Anti-Angiogenic Therapy

An Integrated Multiscale Mechanistic Model for Cancer Drug Therapy

Biomechanical modelling of tumor growth with chemotherapeutic treatment: A review

Modeling of Tumor Growth with Input from Patient-Specific Metabolomic Data

Integrating a dynamic central metabolism model of cancer cells with a hybrid 3D multiscale model for vascular hepatocellular carcinoma growth

A Multiscale Model for Hypoxia-induced Avascular Tumor Growth

Bridging Scales: a Hybrid Model to Simulate Vascular Tumor Growth and Treatment Response

A hybrid model of tumor growth and angiogenesis: In silico experiments

A 3-dimentional multiscale model to simulate tumor progression in response to interactions between cancer stem cells and tumor microenvironmental factors

Multi-scale Agent-Based Modeling on Melanoma and Its Related Angiogenesis Analysis.

A Hybrid Cellular Automaton Model of Solid Tumor Growth and Bioreductive Drug Transport